The question "are peptides legal?" doesn't have a yes-or-no answer. Some peptides are FDA-approved drugs. Some are legally compoundable with a prescription. Some are in regulatory limbo. And some are sold as "research chemicals" that shouldn't be injected into any human being.
Here's how it actually works in 2026.
The Three Categories of Peptide Legality
FDA-Approved Peptides
These are peptides that have gone through the full FDA approval process — clinical trials, safety reviews, manufacturing standards. They're prescribed by physicians for specific indications. They're as "legal" as any prescription medication.
Examples:
- Semaglutide — FDA-approved as Wegovy (weight loss) and Ozempic (type 2 diabetes)
- Tirzepatide — FDA-approved as Zepbound (weight loss) and Mounjaro (type 2 diabetes)
- PT-141 (bremelanotide) — FDA-approved as Vyleesi for hypoactive sexual desire disorder
- Tesamorelin — FDA-approved for HIV-associated lipodystrophy
- Sermorelin — Has FDA history as a diagnostic agent
These are the clearest cases. Physician prescribes it, pharmacy fills it, you take it. Standard medicine.
Category 1: Legally Compoundable
Category 1 peptides can be compounded by licensed pharmacies under section 503A or 503B of the Federal Food, Drug, and Cosmetic Act. They've been reviewed and the FDA has determined there's adequate data to support their safety for compounding.
What "compounding" means: a licensed pharmacy prepares a customized medication based on a physician's prescription. This is legal and common in medicine — it's how pharmacies create specific dosages, formulations, or combinations that aren't commercially available.
Category 1 peptides currently include:
- Sermorelin — Growth hormone secretagogue. Widely prescribed for anti-aging and GH support.
- NAD+ — Cellular health and longevity. Available as injection, nasal spray, or IV.
- Thymosin alpha-1 — Immune support peptide.
- GHK-Cu — Copper peptide used for skin and tissue health.
- AOD 9604 — A fragment of growth hormone studied for fat reduction.
If your physician prescribes a Category 1 peptide, a licensed US pharmacy can legally compound it. The legal path is clear.
Category 2: Compounding Restricted
Category 2 peptides are where things get complicated. These are peptides that the FDA has determined lack sufficient safety data for compounding. Compounding is restricted pending further review.
This doesn't mean they're "illegal" in the way most people understand the word. It means licensed pharmacies can't legally compound them for human use under current guidelines. The peptides themselves aren't controlled substances.
Category 2 includes some of the most popular peptides in the wellness space:
- BPC-157 — The recovery and gut healing peptide
- TB-500 (Thymosin beta-4) — Systemic recovery and anti-inflammatory
- CJC-1295 — Growth hormone releasing hormone analog
- Ipamorelin — Growth hormone secretagogue
- DSIP (Delta sleep-inducing peptide)
- Selank — Anxiolytic peptide
What this means for you: If you're interested in a Category 2 peptide, availability through legitimate medical channels is currently limited. Your physician will discuss what's available during your consultation and may recommend Category 1 or FDA-approved alternatives.
The RFK Reclassification: What's Actually Happening
You may have seen headlines about potential peptide reclassification. Here's what's real and what's not.
The current HHS administration has signaled interest in reclassifying certain Category 2 peptides to Category 1, potentially making them available for legal compounding again. This builds on broader rhetoric about expanding access to peptide therapy and reducing regulatory barriers to patient care.
What's happened so far:
- Public statements from health officials expressing support for peptide access
- Directives to the FDA to review Category 2 classifications
- Industry lobbying from compounding pharmacies and telehealth providers
What hasn't happened yet:
- Formal rulemaking or guidance changes from the FDA
- Official reclassification of any specific peptide
- A clear timeline for when changes might take effect
The direction seems positive for peptide access, but regulatory change is slow. We'll update this page as developments occur. For now, plan based on current rules, not anticipated changes.
"Research Use Only" Peptides: Why You Should Think Twice
Search for almost any peptide online and you'll find vendors selling it as a "research chemical" or "for research use only." These peptides are technically legal to purchase — they're marketed as lab research materials, not medications.
But here's the reality: most people buying these aren't researchers. They're people who intend to inject them. And that's where the risk comes in.
Research-grade peptides are not:
- Prescribed by a physician — nobody evaluates whether this peptide is appropriate for you, at what dose, or whether it'll interact with your medications
- Compounded in a licensed pharmacy — they're manufactured in unregulated facilities, often overseas
- Tested to pharmaceutical standards — no guaranteed purity, no sterility testing, no endotoxin screening
- Accurately dosed — what the label says and what's in the vial may not match
- Covered by any legal protection — if something goes wrong, you have no recourse
We're not trying to scare you. We're being direct: injecting unregulated chemicals into your body without medical oversight is a risk you don't need to take. Legitimate peptide therapy through a licensed physician and pharmacy removes these risks entirely.
Peptide-by-Peptide Legal Status
| Peptide | Status | Notes |
|---|---|---|
| Semaglutide | FDA-approved | Approved for obesity and T2 diabetes. Compounded versions have specific legal considerations. |
| Tirzepatide | FDA-approved | Approved for obesity and T2 diabetes. |
| Sermorelin | Category 1 | Legally compoundable. One of the safest regulatory positions. |
| PT-141 | FDA-approved | Approved as Vyleesi for HSDD. |
| NAD+ | Category 1 | Legally compoundable for injection, IV, nasal. |
| Tesamorelin | FDA-approved | Approved for HIV lipodystrophy. |
| BPC-157 | Category 2 | Compounding restricted. Potential reclassification pending. |
| TB-500 | Category 2 | Compounding restricted. Potential reclassification pending. |
| CJC-1295 | Category 2 | Compounding restricted. |
| Ipamorelin | Category 2 | Compounding restricted. |
State-by-State Telehealth Considerations
Even when a peptide is legally compoundable, telehealth prescribing depends on state law. Here's what varies:
- Physician licensing: The prescribing physician must be licensed in your state, or hold a multi-state license that covers your state.
- Telehealth prescribing rules: Most states allow telehealth prescribing for peptides, but some require an initial in-person visit for certain controlled substances. Peptides generally aren't controlled substances, which simplifies telehealth prescribing.
- Pharmacy shipping: The compounding pharmacy must be licensed to ship to your state. Most major 503A and 503B pharmacies hold multi-state licenses.
- State-specific regulations: A few states have additional requirements or restrictions on compounded medications. Your provider should know which apply to you.
The practical reality: telehealth peptide therapy is available in the vast majority of US states. If your provider is reputable, they've already navigated the state-by-state licensing requirements. Ask them specifically about your state if you're unsure.
How to Stay on the Right Side of the Law
Simple rules:
- Get a prescription from a licensed physician. This is the foundation. A real doctor evaluating your health and writing a prescription.
- Use a licensed US pharmacy. Verify the pharmacy — check their state license, look for 503A or 503B registration.
- Don't buy "research" peptides for personal use. It's a legal and safety risk you don't need to take.
- Stick with Category 1 or FDA-approved peptides if legal clarity matters to you. These have the clearest regulatory path.
- Stay informed. The regulatory landscape is changing. What's Category 2 today might be Category 1 next year.